CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$999,994. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-09 | Turner Heather D Former EVP, GC & Sec. | Sale | −4,596 | $36.63 | $168K | 77,112 |
| 2018-02-09 | Turner Heather D Former EVP, GC & Sec. | Sale | −4,123 | $37.38 | $154K | 72,989 |
| 2018-02-09 | Turner Heather D Former EVP, GC & Sec. | Sale | −600 | $38.63 | $23K | 72,389 |
| 2018-02-09 | Turner Heather D Former EVP, GC & Sec. | Sale | −733 | $39.66 | $29K | 71,656 |
| 2018-02-09 | Turner Heather D Former EVP, GC & Sec. | Sale | −600 | $40.62 | $24K | 71,056 |
| 2018-02-09 | Turner Heather D Former EVP, GC & Sec. | Sale | −1,562 | $41.69 | $65K | 69,494 |
| 2018-02-09 | Clark Mitchall G. EVP & Chief R & QA Officer | Shares withheld for taxes | −3,704 | $41.70 | $154K | 179,913 |
| 2018-02-09 | Haqq Christopher EVP, R&D & Chief Scientific Of | Shares withheld for taxes | −4,925 | $41.70 | $205K | 350,679 |
| 2018-02-09 | Soffer Gad EVP & Chief Strategy Officer | Shares withheld for taxes | −4,169 | $41.70 | $174K | 265,580 |
| 2018-02-09 | MCGRATH JOHN EVP & Chief Financial Officer | Shares withheld for taxes | −4,819 | $41.70 | $201K | 105,556 |
| 2018-02-09 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,200 | $36.59 | $80K | 285,078 |
| 2018-02-09 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,100 | $37.43 | $41K | 283,978 |
| 2018-02-09 | Ciechanover Isaac E. Chief Executive Officer | Sale | −400 | $38.68 | $15K | 283,578 |
| 2018-02-09 | Ciechanover Isaac E. Chief Executive Officer | Sale | −400 | $40.79 | $16K | 283,178 |
| 2018-02-09 | Ciechanover Isaac E. Chief Executive Officer | Sale | −300 | $41.70 | $13K | 282,878 |
| 2018-02-08 | Ciechanover Isaac E. Chief Executive Officer | Sale | −4,400 | $37.15 | $163K | 287,278 |
| 2018-02-06 | Turner Heather D EVP, General Counsel & Sec. | Shares withheld for taxes | −4,434 | $35.80 | $159K | 81,708 |
| 2018-02-06 | Haqq Christopher EVP, R&D & Chief Scientific Of | Grant or award | +17,500 | 360,030 | ||
| 2018-02-06 | Haqq Christopher EVP, R&D & Chief Scientific Of | Shares withheld for taxes | −4,426 | $35.80 | $158K | 355,604 |
| 2018-02-06 | Haqq Christopher EVP, R&D & Chief Scientific Of | Grant or award · Employee Stock Option (Right to Buy) | +35,000 | 35,000 |
Page 36 of 44 · 867 trades